Sponsors (45)
The resolution increases recognition of PCOS — likely improving diagnosis, research attention, and mental-health screening for affected women — but may raise costs for patients and taxpayers and create expectations for treatments that the bill does not itself provide.
Women and girls with PCOS would gain federal recognition of the condition, making it more likely they receive earlier diagnosis and better-targeted clinical care.
Patients with PCOS and related comorbidities could see increased federal research funding and public-health programs as a result of official acknowledgement of PCOS's clinical and economic burden.
People with PCOS (especially women) could benefit from improved screening and treatment for associated mental-health issues such as depression, anxiety, and suicide risk due to explicit recognition of those links.
Many women with PCOS could face increased healthcare utilization and higher out-of-pocket medical costs if the condition is more widely labeled and managed as a chronic disease.
Taxpayers could incur additional costs if new federal programs or research funding related to PCOS are enacted following the resolution's findings.
Women with PCOS may have heightened expectations for new cures or treatments from federal recognition, yet the resolution provides no concrete treatment guidance, risking frustration and disappointment.
Based on analysis of 2 sections of legislative text.
Records congressional findings on PCOS prevalence, symptoms, long-term health risks, diagnosis gaps, genetic links, and economic burden to raise awareness.
Declares and records congressional findings about polycystic ovary syndrome (PCOS), summarizing how common it is, the typical symptoms, the long-term health risks (including metabolic, cardiovascular, reproductive, and mental-health consequences), economic burden estimates, the high rate of undiagnosed cases, and that there is currently no cure. It emphasizes that PCOS often begins in puberty, persists across the life course, and is linked genetically to several metabolic and psychiatric conditions.
Official title: Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September as "PCOS Awareness Month".
Introduced February 27, 2025 by David Scott · Last progress February 27, 2025